Previous 10 | Next 10 |
SEATTLE, WA / ACCESSWIRE / November 16, 2020 / Aptevo Therapeutics Inc. ("Aptevo") (NASDAQ:APVO), a biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ bispecific technology platform, and Alligator Bioscience ("Alligator") (...
Aptevo Therapeutics (APVO): Q3 GAAP EPS of -$2.15 misses by $0.10.Revenue of $1.46M beats by $0.9M.Shares -7%.Press Release For further details see: Aptevo Therapeutics EPS misses by $0.10, beats on revenue
$1.5 million of RUXIENCE ® Royalties Earned in the Third Quarter Funding Extends Cash Runway Into Q3 2021 SEATTLE, WA / ACCESSWIRE / November 10, 2020 / Aptevo Therapeutics Inc. ("Aptevo" or "the Company") (NASDAQ:APVO), a biotechnology company focused on developing novel i...
Gainers: Greenland Technologies (GTEC) +170%.Revlon (REV) +86%.Summit Wireless Technologies (WISA) +50%.Trxade Group (MEDS) +29%.Inovio Pharmaceuticals (INO) +23%.Xperi Holding (XPER) +21%.Pulse Biosciences (PLSE) +21%.Aptevo Therapeutics (APVO) +21%.Boqii Holding (BQ) +20%.StarTek (SRT)...
Gainers: Sundial Growers (SNDL) +79%.Aptevo Therapeutics (APVO) +60%.AMC Entertainment (AMC) +60%.Ashford Hospitality Trust (AHT) +58%.Cinemark Holdings (CNK) +56%.National CineMedia (NCMI) +48%.Tuniu (TOUR) +41%.EPR Properties (EPR) +41%.Dave & Buster's Entertainment (PLAY) +40%.Bro...
SEATTLE, WA / ACCESSWIRE / November 9, 2020 / Aptevo Therapeutics Inc. ("Aptevo") (NASDAQ:APVO), a biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ bispecific technology platform, today announced that it will present two ...
Palm Beach, FL –November 9, 2020 – Much time and money has been allocated in the global breast cancer drug market, and multiple reports project continued growth in the sector. Early detection, increase in awareness, and incidence of breast cancer are some of the key trends sto...
In addition to the one previously announced, Aptevo Therapeutics (APVO) says a second patient in cohort 6 has achieved complete remission ((CR)) in a Phase 1 trial evaluating its lead candidate APVO436 in patients with acute myeloid leukemia and myelodysplastic syndromes.Patient bone mar...
Second Complete Remission Observed in a Patient in Cohort 6 Enrollment in Cohort 8 Has Started SEATLLE, WA / ACCESSWIRE / November 9, 2020 / Aptevo Therapeutics Inc. ("Aptevo") (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therape...
Aptevo Therapeutics (APVO) rose 113% premarket, currently trading at $50.52 after Tang Capital Partners reported a 54.4% stake in new 13D regulatory filing.The reporting persons have expended an aggregate of ~$28.1M to purchase 1.76M Aptevo shares through the open market.APVO share price...
News, Short Squeeze, Breakout and More Instantly...
Aptevo Therapeutics Inc. Company Name:
APVO Stock Symbol:
NASDAQ Market:
Aptevo Therapeutics Inc. Website:
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 113.3% to $0.3178 on volume of 162,323,665 shares NVIDIA Corporation (NVDA) rose 0.8% to $118.92 on volume of 44,858,282 shares Maxeon Solar Technologies Ltd. (MAXN) rose 8.5% to $0.2648 on volume of 43,008,...
2024-07-18 06:16:00 ET 3 Tips for Using RSI When Investing in Penny Stocks Relative Strength Index (RSI) is a powerful tool for evaluating the momentum of stocks, and it can be particularly effective when investing in penny stocks . Penny stocks offer unique opportunities due to the...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 6.6% to $117.99 on volume of 383,510,118 shares Aptevo Therapeutics Inc. (APVO) rose 73.4% to $0.581 on volume of 315,289,581 shares PROSHARES TRUST (SQQQ) rose 8.7% to $8.11 on volume of 173,682,364 sha...